Detalles de la búsqueda
1.
Therapeutic Immunization against Glioblastoma.
Int J Mol Sci
; 19(9)2018 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-30150597
2.
A Prospective, Cohort Study of SITOIGANAP to Treat Glioblastoma When Given in Combination With Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Nivolumab or Granulocyte-Macrophage Colony-Stimulating Factor/Cyclophosphamide/Bevacizumab/Pembrolizumab in Patients Who Failed Prior Treatment With Surgical Resection, Radiation, and Temozolomide.
Front Oncol
; 12: 934638, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35837107
3.
A Retrospective Interventional Cohort Study to Assess the Safety and Efficacy of Sandostatin LAR for Treatment of Recurrent and/or Refractory Meningiomas.
Front Neurol
; 11: 373, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32435228
4.
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
CNS Oncol
; 7(3): CNS22, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30157683
Resultados
1 -
4
de 4
1
Próxima >
>>